The EVER trial reported 12-month outcomes after early mobilization in patients with sepsis and respiratory failure, finding that starting movement earlier did not translate into better longer-term recovery outcomes. The study adds nuance to a strategy that has been widely adopted in intensive care settings with the goal of mitigating physical consequences of prolonged mechanical ventilation and critical illness. While early mobilization is often implemented as a quality improvement effort, the trial results did not confirm sustained benefit at the longer follow-up window. Clinicians and trial designers are likely to reassess which subgroups—such as patients with certain functional limitations or disease trajectories—might benefit more from mobility interventions. The findings underline that ICU supportive-care practices still require evidence linking execution to durable patient-centered endpoints beyond short-term measures.